Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report

Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report

Abstract Background Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. Dermatologic toxicity of all grades occurs in more than 90% of patients. However, there are few reports of purpura induced by anti-epidermal growth factor receptor antibody...

Full description

Bibliographic Details
Main Authors: Hitomi Kamo, Eiji Shinozaki, Takanobu Sugase, Nobuyuki Mizunuma, Shoji Taniguchi, Takashi Gotoh, Keisyo Chin, Tomoaki Tanaka, Kazumi Koga, Kensei Yamaguchi
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Journal of Medical Case Reports
Subjects:
Anti-EGFR antibody
Colon cancer
Renal toxicity
Purpura
Leukocytoclastic vasculitis
Panitumumab
Online Access:http://link.springer.com/article/10.1186/s13256-018-1877-7

Internet

http://link.springer.com/article/10.1186/s13256-018-1877-7

Similar Items